Neurodevelopmental Disorder clinical trials
20 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Physical Activity and Community EmPOWERment Project
- Genetic Inclusion by Virtual Evaluation
- SLC6A1-NDD Prospective Longitudinal Natural History Study
- Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder
- Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
- Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
- PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders
- Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
- Motor-voice Assessment in Infants (MAMI)
- Patterns of Neurodevelopmental Disorders
- Natural History Study of Patients with HPDL Mutations
- Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations
- Developing Brain, Impulsivity and Compulsivity
- Longitudinal Study of Neurogenetic Disorders
- Reducing Missed Appointments
- School-based Paraeducator Education for Engagement at Recess
- Optimizing Dimensions of Reinforcement
- Gene Therapy for SLC6A1 Neurodevelopmental Disorder
- Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Neurodevelopmental Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.